LI-RADS 静脉癌栓类别在 CT 与肝胆特异性 MRI 的诊断效能
本研究回顾性纳入 2010 至 2019 年间术前行 CT 和肝胆特异性 MRI 且接受肝切除或肝移植的 1322 例患者(101 例有宏观静脉癌栓,1221 例无),以病理为参考标准,评估 LI-RADS 静脉癌栓(LR-TIV)类别的诊断效能。结果显示,无论是否结合提示 TIV 的特征(FSTIV),LR-TIV 类别诊断宏观 TIV 的敏感度中等(62.4%-67.3%),特异度极高(99.7%-99.8%);加入 FSTIV 未显著提升诊断效能。
要点
- LR-TIV 类别诊断宏观静脉癌栓的敏感度中等(约 62%-67%),特异度极高(≈99.8%)。
- 无论 CT 还是肝胆特异性 MRI,LR-TIV 的诊断效能相近,加入 FSTIV 未见显著增益。
- 阅片时需仔细评估静脉内强化软组织,其存在高度提示宏观 TIV,但阴性不能排除。
关键影像表现/征象
- LR-TIV 的影像特征为静脉内强化软组织。
- 在不考虑 FSTIV 时,CT 检测静脉内强化软组织的敏感度为 64.4%(65/101),特异度为 99.8%(1218/1221)。
- 在不考虑 FSTIV 时,肝胆特异性 MRI 检测静脉内强化软组织的敏感度为 62.4%(63/101),特异度为 99.8%(1218/1221)。
- 在考虑 FSTIV 时,CT 和肝胆特异性 MRI 上 LR-TIV 类别的敏感度均为 67.3%(68/101),特异度均为 99.7%(1217/1221)。
诊断标准与关键数值
- LR-TIV 类别诊断宏观 TIV 的敏感度:不考虑 FSTIV 时 CT 为 64.4%(65/101),HBA MRI 为 62.4%(63/101);考虑 FSTIV 时两者均为 67.3%(68/101)。
- LR-TIV 类别诊断宏观 TIV 的特异度:不考虑 FSTIV 时 CT 和 HBA MRI 均为 99.8%(1218/1221);考虑 FSTIV 时两者均为 99.7%(1217/1221)。
- 加入 FSTIV 前后敏感度比较:CT 为 62% vs 67%(P = .45),HBA MRI 为 64% vs 67%(P = .18);特异度均为 99%(P > .99)。
临床应用与阅片要点
- 日常阅片应关注静脉内强化软组织这一 LR-TIV 核心征象,其特异度极高,一旦出现应提示宏观 TIV。
- 敏感度中等提示阴性结果不能排除宏观 TIV,需结合其他征象(如 FSTIV)综合判断。
- CT 与肝胆特异性 MRI 对 LR-TIV 的诊断效能相近,可根据临床可及性选择检查方法。
局限性
- 单中心回顾性研究设计。
- 仅纳入接受肝切除或肝移植的患者,存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Diagnostic performance of the Liver Imaging Reporting and Data System tumor in vein (LR-TIV) category at CT and/or MRI has not yet been evaluated, to the knowledge of the authors. Purpose To assess the diagnostic performance of the LR-TIV category in detecting macroscopic tumors in veins (TIVs) at CT and hepatobiliary contrast agent-enhanced (HBA) MRI, with pathologic results used as the reference standard. Materials and Methods Between January 2010 and December 2019, consecutive patients with or without macroscopic TIV who underwent both CT and HBA MRI before hepatic resection or liver transplant were retrospectively included. Three radiologists independently assessed the LR-TIV features of enhancing soft tissue in vein and features suggestive of TIV (FSTIV) and reached a consensus. Macroscopic TIV at pathologic examination was the reference standard. Sensitivities and specificities of the LR-TIV category without and with FSTIV were calculated, and the added value of FSTIV was evaluated by using the McNemar test. Results In the 1322 patients with (n = 101) or without (n = 1221) macroscopic TIV (median age, 64 years [interquartile range, 58-70 years]; 1053 men), without consideration of FSTIV, the sensitivity and specificity of enhancing soft tissue in vein for detecting macroscopic TIV at pathologic examination were 64.4% (65 of 101) and 99.8% (1218 of 1221) with CT and 62.4% (63 of 101) and 99.8% (1218 of 1221) with HBA MRI, respectively. With consideration of FSTIV, the sensitivity and specificity of the LR-TIV category became 67.3% (68 of 101 patients) and 99.7% (1217 of 1221 patients) at both CT and HBA MRI. No difference was found between measurements without and with FSTIV (sensitivity, 62% vs 67% for CT [P = .45] and 64% vs 67% for HBA MRI [P = .18]; specificity, 99% for both CT and HBA MRI [P > .99 for both]). Conclusion The Liver Imaging Reporting and Data System tumor in vein category showed moderate sensitivity and high specificity in the detection of macroscopic tumors in veins at both CT and hepatobiliary contrast agent-enhanced MRI, with pathologic examination used as the reference standard. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Morrell in this issue.
引用
- Bae JS, Lee JM, Jeon SK, et al. LI-RADS Tumor in Vein at CT and Hepatobiliary MRI. Radiology. 2021. PMID: 34581625. doi:10.1148/radiol.2021210215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。